the starla -- the stall out which for reaffirmation tomorrow from j.p. morgan.han: let's get to the price action here and now. in the bond market, off the back of that headline from the fda and the cdc, recommending the pause of the use of the j&j vaccine, yields were lower for about five minute, now higher on the session by a basis point on 10's. that's your price action off the back of an important conversation. romaine, so far the price action is not so dramatic. romaine: not too dramatic here. this going to be a short-term knee-jerk reaction when that j&j news crossed the wire. we did see about 20 points are so shaved off of s&p futures. we should point out that j&j is a relatively heavy weighted company. i think it is the 10th highest weighted company in the s&p 500. so in this premarket pricing, down about 3%, if that holds into the open, you will definitely see a little bit of a drag, at least in the short term. it might help some competitors. moderna getting a bid, pfizer as well. outside the pharmaceutical space and outside of everything going on with t